Viridian Therapeutics Inc. VRDN
Super Investor & Insider
Nessuna transazione insider negli ultimi 6 mesi.
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
Viridian Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing best-in-class medicines for patients with autoimmune and rare diseases, particularly thyroid eye disease (TED). The company leverages expertise in antibody discovery and protein engineering t…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees252
TickerVRDN
Statistics
Market Cap$1.68B
Revenue (TTM)$70.8M
Net Income-$342.6M
Net Margin-483.6%
EPS—
P/E-4.96
P/S24.56
P/B3.21
EV/EBITDA-2.72
ROE-58.1%
Dividend Yield—
Price$16.45
Data: Twelve Data · Revenue = mcap / P/S